Skip to content
Disclosery

Frazier Life Sciences Management, L.P.: ERAS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Frazier Life Sciences Management, L.P. on ERAS, newest first. How the timeline and the estimate are built.

Frazier Life Sciences Management, L.P. held 24,975,188 ERAS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 24,975,188 shares
    Change vs previous 13F +300,000 shares

    9.96% of the 13F portfolio, value $457,545,444.

    13F-HR 0001892134-26-000003 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 24,675,188 shares
    Change vs previous 13F +1,945,752 shares

    10.27% of the 13F portfolio, value $399,244,542.

    13F-HR 0001892134-26-000002 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 22,729,436 shares
    Change vs previous 13F 0 shares

    2.27% of the 13F portfolio, value $84,553,502.

    13F-HR 0001892134-26-000001 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 22,729,436 shares
    Change vs previous 13F 0 shares

    1.48% of the 13F portfolio, value $49,550,170.

    13F-HR 0001892134-25-000012 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 22,729,436 shares
    Change vs previous 13F +153,585 shares

    1.15% of the 13F portfolio, value $28,866,384.

    13F-HR 0001892134-25-000006 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 22,575,851 shares
    Change vs previous 13F +3,184,164 shares

    1.41% of the 13F portfolio, value $30,928,916.

    13F-HR 0001892134-25-000005 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 19,391,687 shares
    Change vs previous 13F 0 shares

    2.02% of the 13F portfolio, value $48,673,134.

    13F-HR 0001892134-25-000001 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 19,391,687 shares
    Change vs previous 13F not available

    2.12% of the 13F portfolio, value $52,939,306.

    13F-HR 0001892134-24-000006 filed by Frazier Life Sciences Management, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).